Tema Oncology ETF (NASDAQ:CANC) Short Interest Update

Tema Oncology ETF (NASDAQ:CANC) was the target of a significant drop in short interest in April. As of April 30th, there was short interest totaling 8,604 shares, a drop of 67.6% from the April 15th total of 26,566 shares. Based on an average daily trading volume, of 36,832 shares, the days-to-cover ratio is currently 0.2 days. Currently, 0.2% of the shares of the stock are sold short.

Tema Oncology ETF Trading Down 2.3%

Shares of CANC stock traded down $0.88 during mid-day trading on Friday, reaching $37.09. The stock had a trading volume of 13,496 shares, compared to its average volume of 32,288. Tema Oncology ETF has a 12-month low of $22.78 and a 12-month high of $39.95. The company has a market cap of $173.95 million, a P/E ratio of 20.39 and a beta of 0.74. The business has a 50-day simple moving average of $37.22 and a 200 day simple moving average of $35.85.

Institutional Trading of Tema Oncology ETF

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in CANC. Roxbury Financial LLC purchased a new stake in Tema Oncology ETF during the 1st quarter worth about $34,000. Jane Street Group LLC purchased a new stake in Tema Oncology ETF during the 1st quarter worth about $213,000. LPL Financial LLC purchased a new stake in Tema Oncology ETF during the 4th quarter worth about $278,000. Flow Traders U.S. LLC purchased a new stake in Tema Oncology ETF during the 3rd quarter worth about $630,000. Finally, Thrivent Financial for Lutherans increased its position in Tema Oncology ETF by 891.1% during the 4th quarter. Thrivent Financial for Lutherans now owns 1,461,649 shares of the company’s stock worth $50,747,000 after purchasing an additional 1,314,177 shares in the last quarter.

About Tema Oncology ETF

The Tema Oncology ETF (CANC) is an exchange-traded fund that mostly invests in health care equity. The fund is actively managed, investing in stocks of companies focused on cancer treatment and management from issuers all around the world. The fund uses a bottom-up approach to select pioneering companies at perceived attractive valuations CANC was launched on Aug 15, 2023 and is issued by Tema.